Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
S. Palacios, M. Ramirez & M. Lilue. (2022) Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy. Climacteric 25:4, pages 383-387.
Read now
Read now
Carmen Pingarrón, Pilar Lafuente, Silvia Poyo Torcal, Helena López Verdú, María Sol Martínez García & Santiago Palacios. (2022) Vaginal health, endometrial thickness and changes in bone markers in postmenopausal women after 6 months of treatment with ospemifene in real clinical practice. Gynecological Endocrinology 38:1, pages 78-82.
Read now
Read now
Angelo Cagnacci, Anjeza Xholli & Martina Venier. (2020) Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use. Patient Preference and Adherence 14, pages 55-62.
Read now
Read now
James H. Liu, Brian Bernick & Sebastian Mirkin. (2020) Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion. Expert Opinion on Drug Delivery 17:11, pages 1573-1581.
Read now
Read now
M. Shapiro. (2019) What should guide our patient management of vulvovaginal atrophy?. Climacteric 22:1, pages 38-43.
Read now
Read now
Michele Carlo Schiavi, Valentina Sciuga, Andrea Giannini, Flaminia Vena, Ottavia D’oria, Giovanni Prata, Chiara Di Tucci, Delia Savone, Natalia Aleksa, Carmela Capone, Daniele Di Mascio, Maria Letizia Meggiorini, Marco Monti, Marzio Angelo Zullo, Ludovico Muzii & Pierluigi Benedetti Panici. (2018) Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality?. Gynecological Endocrinology 34:8, pages 666-669.
Read now
Read now
Michele Carlo Schiavi, Anna Di Pinto, Valentina Sciuga, Pierangelo Faiano, Chiara Di Tucci, Ottavia D’oria, Angela Martoccia, Giovanni Prata, Carlo Carraro, Rosa Ostuni, Marzio Angelo Zullo, Ludovico Muzii & Pierluigi Benedetti Panici. (2018) Prevention of recurrent lower urinary tract infections in postmenopausal women with genitourinary syndrome: outcome after 6 months of treatment with ospemifene. Gynecological Endocrinology 34:2, pages 140-143.
Read now
Read now
Mary Jane Minkin, Ricardo Maamari & Suzanne Reiter. (2014) Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy. International Journal of Women's Health 6, pages 281-288.
Read now
Read now
Articles from other publishers (21)
Ahmed Abdelgader, Mershen Govender, Pradeep Kumar & Yahya E. Choonara. (2023) Intravaginal Drug Delivery Systems to Treat the Genitourinary Syndrome of Menopause: Towards the Design of Safe and Efficacious Estrogen-loaded Prototypes. Journal of Pharmaceutical Sciences 112:6, pages 1566-1585.
Crossref
Crossref
Rita Palmeira-de-Oliveira, Ana Sofia Oliveira, Joana Rolo, Mariana Tomás, Ana Palmeira-de-Oliveira, Sérgio Simões & José Martinez-de-Oliveira. (2022) Women’s preferences and acceptance for different drug delivery routes and products. Advanced Drug Delivery Reviews 182, pages 114133.
Crossref
Crossref
Saikat Mitra, Mashia Subha Lami, Avoy Ghosh, Rajib Das, Trina Ekawati Tallei, Fatimawali, Fahadul Islam, Kuldeep Dhama, M. Yasmin Begum, Afaf Aldahish, Kumarappan Chidambaram & Talha Bin Emran. (2022) Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?. Cancers 14:3, pages 759.
Crossref
Crossref
亚丽 刘. (2022) Research Progress of Urinary Symptoms in Postmenopausal Women. Advances in Clinical Medicine 12:05, pages 4137-4142.
Crossref
Crossref
Christina Escobar & Nirit Rosenblum. (2021) Vaginal Estrogen—What a Urologist Should Know. Urology 151, pages 37-43.
Crossref
Crossref
Tahereh Poordast, Lida Ghaedian, Leila Ghaedian, Fatemeh Sadat Najib, Shohreh Alipour, Massood Hosseinzadeh, Hossein Molavi Vardanjani, Alireza Salehi & Seyed Jalal Hosseinimehr. (2021) Aloe Vera; A new treatment for atrophic vaginitis, A randomized double-blinded controlled trial. Journal of Ethnopharmacology 270, pages 113760.
Crossref
Crossref
Allison M. Quick, Travis Dockter, Jennifer Le-Rademacher, Ritu Salani, Catherine Hudson, Andrew Hundley, Shelby Terstriep, Lauren Streicher, Stephanie Faubion, Charles L. Loprinzi, Jenell S. Coleman, Karen C. Wang & Maryam Lustberg. (2021) Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors. Maturitas 144, pages 37-44.
Crossref
Crossref
G.O. Grechkanev, T.V. Kotova, T.S. Kachalina, I.A. Kuznetsova, D.S. Krupinova, N.N. Nikishov & Kh.M. Klemente. (2021) Modern possibilities of conservative treatment of women with pelvic organ prolapse. Rossiiskii vestnik akushera-ginekologa 21:3, pages 46.
Crossref
Crossref
Shannon L. Wallace, Brad St Martin, Kyueun Lee & Eric R. Sokol. (2020) A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia. American Journal of Obstetrics and Gynecology 223:6, pages 890.e1-890.e12.
Crossref
Crossref
Ginger Constantine, Leah S. Millheiser, Andrew M. Kaunitz, Sharon J. Parish, Shelli GrahamBrian BernickSebastian Mirkin. (2019) Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia. Menopause 26:11, pages 1259-1264.
Crossref
Crossref
Brooke M Faught, Graziella Soulban, Jason Yeaw, Christiane Maroun, Katharine Coyle, Samuel Schaffer & Mitch DeKoven. (2019) Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia. Journal of Comparative Effectiveness Research 8:13, pages 1111-1123.
Crossref
Crossref
Kumaraswamy Naidu Chitrala, Mitzi Nagarkatti, Prakash Nagarkatti & Suneetha Yeguvapalli. (2019) Analysis of the TP53 Deleterious Single Nucleotide Polymorphisms Impact on Estrogen Receptor Alpha-p53 Interaction: A Machine Learning Approach. International Journal of Molecular Sciences 20:12, pages 2962.
Crossref
Crossref
David F. Archer, Steven R. Goldstein, James A. Simon, Arthur S. Waldbaum, Steven A. Sussman, Corrado Altomare, Julie Zhu, Yuki Yoshida, Sam Schaffer & Graziella Soulban. (2019) Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial. Menopause 26:6, pages 611-621.
Crossref
Crossref
Sheryl A. Kingsberg, Robin Kroll, Irwin Goldstein, Harvey Kushner, Brian Bernick, Shelli Graham, Sebastian Mirkin & Ginger D. Constantine. (2017) Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HR. Menopause 24:8, pages 894-899.
Crossref
Crossref
Alina Weissmann-Brenner, Tuvia Bayevsky & Israel Yoles. (2017) Compliance to vaginal treatment—tablets versus cream: a retrospective 9 years study. Menopause 24:1, pages 73-76.
Crossref
Crossref
Jijin Gu & Emmanuel A. Ho. 2015. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials
2712
2725
.
David Portman, Lee Shulman, Jason Yeaw, Sha Zeng, Chioma Uzoigwe, Ricardo Maamari & Neeraj N. Iyer. (2015) One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy. Menopause 22:11, pages 1197-1203.
Crossref
Crossref
M. A. Weber, J. Limpens & J. P. W. R. Roovers. (2014) Assessment of vaginal atrophy: a review. International Urogynecology Journal 26:1, pages 15-28.
Crossref
Crossref
D. Portman, S. Palacios, R.E. Nappi & A.O. Mueck. (2014) Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: A randomised, placebo-controlled, phase III trial. Maturitas 78:2, pages 91-98.
Crossref
Crossref
Matthew S. Fine. (2014) Role of Topical Vaginal Estrogen in the Treatment of Overactive Bladder. Current Bladder Dysfunction Reports 9:1, pages 58-62.
Crossref
Crossref
Rachna Rastogi, Ryan S. Teller, Pedro M.M. Mesquita, Betsy C. Herold & Patrick F. Kiser. (2013) Osmotic pump tablets for delivery of antiretrovirals to the vaginal mucosa. Antiviral Research 100:1, pages 255-258.
Crossref
Crossref